Format

Send to

Choose Destination
Lung. 2017 Apr;195(2):201-208. doi: 10.1007/s00408-016-9973-1. Epub 2016 Dec 22.

Non-steroidal Anti-inflammatory Drugs may Worsen the Course of Community-Acquired Pneumonia: A Cohort Study.

Author information

1
Respiratory and Intensive Care Unit, University Hospital Amiens, Amiens, 80054, France. basille.damien@chu-amiens.fr.
2
Recif Unit, University Hospital Amiens, Amiens, France. basille.damien@chu-amiens.fr.
3
Respiratory and Intensive Care Unit, University Hospital Amiens, Amiens, 80054, France.
4
Recif Unit, University Hospital Amiens, Amiens, France.
5
Internal Medicine, University Hospital Amiens, Amiens, France.

Abstract

PURPOSE:

Non-steroidal anti-inflammatory drugs (NSAIDs) are frequently prescribed or used as self-medication in cases of community-acquired pneumonia (CAP). Nevertheless, the consequences of such medication on the risk of pleuroparenchymal complications are not well known. The aim was to investigate whether exposure to NSAIDs prior to hospital admission among patients suffering from CAP is associated with the development of pleural complications or a lung abscess.

METHODS:

All consecutive non-immunocompromised patients with CAP and admitted to a university hospital were prospectively included (2-year period). The risk of pleuropulmonary complications was analyzed according to previous exposure to NSAIDs.

RESULTS:

Of the 221 included patients, 40 (18.1%) had developed a pleuropulmonary complication. NSAIDs intake prior to admission was reported for 24 patients (10.9%) who were younger (50.6 ± 18.5 vs. 66.5 ± 16.4 years; p = 0.001), had less comorbidities (60 vs. 25.1%; p = 0.001), had a longer duration between the first symptoms of CAP and the start of an antibiotic therapy (6.1 ± 7.6 vs. 2.8 ± 3.8 days; p = 0.001), and who had a higher incidence of pleuropulmonary complications (33.3 vs. 16.2%; p = 0.048). In multivariate analyses, two factors were independently associated with the development of pleuroparenchymal complications: NSAIDs intake [Odds Ratio (OR) = 2.57 [1.02-6.64]; p = 0.049] and alcohol abuse (OR = 2.68 [1.27-5.69]; p = 0.01).

CONCLUSIONS:

Our findings suggest that NSAIDs, often taken by young and healthy patients, may worsen the course of CAP with delayed therapy and a higher rate of pleuropulmonary complications.

KEYWORDS:

Community-acquired pneumonia; Empyema; Lung abscess; Non-steroidal anti-inflammatory drug; Parapneumonic effusion

PMID:
28005149
DOI:
10.1007/s00408-016-9973-1
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center